ClinConnect ClinConnect Logo
Search / Trial NCT05527769

Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique

Launched by INSTITUT CANCEROLOGIE DE L'OUEST · Sep 2, 2022

Trial Information

Current as of June 12, 2025

Completed

Keywords

ClinConnect Summary

describe the occurrence of complications between pre-pectoral and retro-pectoral technique in patients with breast cancer who have total mastectomy.

evaluate the postoperative pain by Brief Pain Inventory (BPI) self assesment observe the functional results of the homolateral upper limb by Disabilities of the Arm, Shoulder and Hand (DASH) self assesment observe quality of life by BREAST Q questionary

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Major patients
  • 2. With breast cancer and indication for total mastectomy
  • 3. With a desire for immediate breast reconstruction
  • 4. Total mastectomy procedure and Immediate Breast Reconstruction by Pre-pectoral or Retro-Pectoral prosthesis
  • 5. Information of the patient and collection of his/her non-opposition
  • 6. Affiliation with a social securitý scheme, or beneficiary of such a scheme
  • Exclusion Criteria:
  • 1. Prophylactic mastectomies
  • 2. Metastatic patients
  • 3. Patients requiring another surgical technique
  • 4. Person in an emergency situation, person of legal age under legal protection (adult under guardianship, curators or safeguard of justice), or unable to express consent,
  • 5. Impossibility to submit to the medical follow-up of the trial for geographical, social or psychological reasons
  • 6. Pregnant or likely to be pregnant

About Institut Cancerologie De L'ouest

The Institut de Cancérologie de l'Ouest (ICO) is a leading French cancer research and treatment center dedicated to advancing oncology through innovative clinical trials and multidisciplinary care. As a key player in the fight against cancer, ICO integrates cutting-edge research with clinical practice, focusing on personalized medicine and patient-centered approaches. With a commitment to improving patient outcomes, ICO collaborates with academic institutions and industry partners to develop novel therapies and enhance understanding of cancer biology. The institute's expertise spans various cancer types, making it a pivotal hub for oncological research and education in France and beyond.

Locations

Saint Herblain, , France

Patients applied

0 patients applied

Trial Officials

Céline RENAUDEAU, MD

Principal Investigator

celine.renaudeau@ico.unicancer.fr

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials